1. TRNA deamination by ADAT requires substrate-specific recognition mechanisms and can be inhibited by tRFs
- Author
-
Àlbert Rafels-Ybern, Miquel Coll, Jorge García-Lema, Albert Canals, Maria Castellví Coma, Helena Roura Frigolé, Noelia Camacho, Carla Fernández-Lozano, and Lluís Ribas de Pouplana
- Subjects
Adenosine ,Adenosine Deaminase ,Deamination ,Gene Expression ,RNA, Transfer, Ala ,RNA, Transfer, Arg ,Biology ,Article ,Substrate Specificity ,Evolution, Molecular ,03 medical and health sciences ,Adenosine deaminase ,medicine ,Anticodon ,Humans ,tRF ,Inosine ,Molecular Biology ,tRNA ,030304 developmental biology ,chemistry.chemical_classification ,0303 health sciences ,Base Sequence ,030302 biochemistry & molecular biology ,Substrate (chemistry) ,ADAT ,Enzyme ,chemistry ,Biochemistry ,Transfer RNA ,biology.protein ,Deaminase ,Nucleic Acid Conformation ,Sequence Alignment ,medicine.drug - Abstract
Adenosine deaminase acting on transfer RNA (ADAT) is an essential eukaryotic enzyme that catalyzes the deamination of adenosine to inosine at the first position of tRNA anticodons. Mammalian ADATs modify eight different tRNAs, having increased their substrate range from a bacterial ancestor that likely deaminated exclusively tRNAArg. Here we investigate the recognition mechanisms of tRNAArg and tRNAAla by human ADAT to shed light on the process of substrate expansion that took place during the evolution of the enzyme. We show that tRNA recognition by human ADAT does not depend on conserved identity elements, but on the overall structural features of tRNA. We find that ancestral-like interactions are conserved for tRNAArg, while eukaryote-specific substrates use alternative mechanisms. These recognition studies show that human ADAT can be inhibited by tRNA fragments in vitro, including naturally occurring fragments involved in important regulatory pathways.
- Published
- 2019